DUBLIN, January 06, 2022--(BUSINESS WIRE)--The \"Synthetic Biology Market Size, Share & Trends Analysis Report by Product (Enzymes, Cloning Technologies Kits), by Technology (PCR, NGS), by Application (Non-Healthcare, Healthcare), by End Use, and Segment Forecasts, 2021-2027\" report has been added to ResearchAndMarkets.com's offering.<\/p>\n
The global synthetic biology market size is estimated to reach USD 31.97 billion by 2027, registering a CAGR of 20.8%<\/p>\n
Extensive applications of synthetic biology in multiple fields is a major impact rendering driver of the market. For instance, the technique is used for the development of biofuel from microorganisms in the bioenergy field.<\/p>\n
Several market participants have produced materials and textiles with the use of synthetic biology. Bolt Threads, a material developing company that produced engineered spider silk ties, and Colorifix are developing dyes with biological systems.<\/p>\n
In addition, the market has provided the agriculture industry with alternative fertilizer options, which are not harmful. For instance, Pivot Bio, a California-based company, has established a technique of fertilizing crops without relying on a harmful polluting chemical process.<\/p>\n
Extending clinical applications of synthetic biology, the potential of the technique to accelerate drug development, and enhancing market competition are some key aspects driving the industry. The COVID-19 pandemic is set to drive applications and investments in this space.<\/p>\n
For instance, in January 2021, FDA approved Phase III trials of carrimycin - a synthetic biological drug treatment for COVID-19. This drug includes anti-inflammatory, antiviral, anti-fibrosis, as well as antibacterial effects.<\/p>\n
Synthetic Biology Market Report Highlights<\/p>\n
Oligonucleotide\/oligo pools and synthetic DNA held the dominant share in the product segment owing to the increased application scope of the product in the research field<\/p>\n
The enzymes product segment is expected to witness the second-fastest CAGR over the forecast years owing to the growing application of enzymes in biofuel, textile industry, and molecular biology applications<\/p>\n
Healthcare application is the largest revenue-generating as well as the fastest-growing application segment due to a rise in the application of synthetic biology in research, diagnostics, and other clinical fields<\/p>\n
The biotechnology & pharmaceutical companies end-use segment led the market in 2020 due to heavy investments to enhance R&D activities for the production of vaccines and other drugs<\/p>\n
PCR was the largest revenue-generating technology segment in 2020. With the accelerated development of modern life science, PCR technology has been widely applied to different biological, medical research, virus detection, and the food industry<\/p>\n
The availability of advanced research facilities, increased investments in private companies, favorable regulations, and government assistance & funding have contributed to the dominance of the North America regional market in 2020<\/p>\n
For Instance, in September 2020, a U.S.-based startup, Zymergen Inc., received USD 300 million in funding from Baillie Gifford & Co. to increase the R&D activities in synthetic biology<\/p>\n
The key operating players are focusing on exploring synthetic biology to its highest potential across different emerging applications<\/p>\n
For instance, in April 2020, Barcelona-based Luis Serrano and Maria Lluch received USD 2.35 million of seed financing from Barcelona-based Invivo Ventures to develop novel treatments for lung infections<\/p>\n
Story continues<\/p>\n
Key Topics Covered:<\/p>\n
Chapter 1 Methodology and Scope<\/p>\n
Chapter 2 Executive Summary<\/p>\n
Chapter 3 Market Variables, Trends & Scope<\/p>\n
3.1 Market Segmentation<\/p>\n
3.2 Synthetic Biology Market Lineage Outlook<\/p>\n
3.2.1 Parent Market Outlook<\/p>\n
3.3 Penetration And Growth Prospect Mapping<\/p>\n
3.4 Market Driver Analysis<\/p>\n
3.4.1 Extensive Applications Of Synthetic Biology<\/p>\n
3.4.2 Funding And Assistance From Government And Private Organization<\/p>\n
3.4.3 Growing Research And Development Activities In Synthetic Biology<\/p>\n
3.5 Market Restraint Analysis<\/p>\n
3.5.1 Biosafety, Biosecurity Issue<\/p>\n
3.5.2 Ethical Issues And Unintended Consequences<\/p>\n
3.6 Market Opportunity Analysis<\/p>\n
3.6.1 Development Of Vaccines And Personalized Medicines<\/p>\n
3.6.2 Demand For Biofuel<\/p>\n
3.7 Market Challenge Analysis<\/p>\n
3.7.1 Lack Of Standard Regulation For Synthetic Biology Products<\/p>\n
3.8 Business Environment Analysis<\/p>\n
3.8.1 SWOT Analysis; By Factor (Political & Legal, Economic And Technological)<\/p>\n
3.8.2 Porter's Five Forces Analysis<\/p>\n
3.9 Competitive Analysis<\/p>\n
Chapter 4 Products Business Analysis<\/p>\n
4.1 Synthetic Biology Market: Products Movement Analysis<\/p>\n
4.2 Oligonucleotide\/Oligo Pools And Synthetic Dna<\/p>\n
4.3 Enzymes<\/p>\n
4.4 Cloning Technologies Kits<\/p>\n
4.5 Xeno - Nucleic Acids<\/p>\n
4.6 Chassis Organism<\/p>\n
Chapter 5 Technology Business Analysis<\/p>\n
5.1 Synthetic Biology Market: Technology Movement Analysis<\/p>\n
5.2 Pcr<\/p>\n
5.3 Genome Editing<\/p>\n
5.4 Ngs<\/p>\n
5.5 Bioprocessing Technology<\/p>\n
Chapter 6 Application Business Analysis<\/p>\n
6.1 Synthetic Biology Market: Application Movement Analysis<\/p>\n
6.2 Healthcare<\/p>\n
6.2.1 Global Synthetic Biology Market For Healthcare Synthetic Biology Market Estimates And Forecast, 2018 - 2027 (USD Million)<\/p>\n
6.2.2 Clinical<\/p>\n
6.2.2.1 Global Synthetic Biology Market For Clinical Synthetic Biology Market Estimates And Forecast, 2018 - 2027 (USD Million)<\/p>\n
6.2.2.1.1 Bio\/Pharmaceuticals<\/p>\n
6.2.2.1.2 Diagnostics<\/p>\n
6.2.3 Non - Clinical<\/p>\n
6.3 Non - Healthcare<\/p>\n
Chapter 7 End Use Business Analysis<\/p>\n
7.1 Synthetic Biology Market: End Use Movement Analysis<\/p>\n
7.2 Biotechnology & Pharmaceutical Companies<\/p>\n
7.3 Academic & Government Research Institutes<\/p>\n
Chapter 8 Regional Business Analysis<\/p>\n
8.1 Synthetic Biology Market: Regional Movement Analysis<\/p>\n
Chapter 9 Company Profiles<\/p>\n
For more information about this report visit https:\/\/www.researchandmarkets.com\/r\/gzc6ya<\/a><\/p>\n View source version on businesswire.com: https:\/\/www.businesswire.com\/news\/home\/20220106005512\/en\/<\/a><\/p>\n Contacts<\/p>\n ResearchAndMarkets.comLaura Wood, Senior Press Managerpress@researchandmarkets.com<\/a> For E.S.T Office Hours Call 1-917-300-0470For U.S.\/CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900<\/p>\n <\/p>\n Go here to see the original:<\/p>\n Global Synthetic Biology (Enzymes, Cloning Technologies Kits) Market Report 2021-2027 - Opportunities in the Development of Vaccines and Personalized...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" DUBLIN, January 06, 2022--(BUSINESS WIRE)--The \"Synthetic Biology Market Size, Share & Trends Analysis Report by Product (Enzymes, Cloning Technologies Kits), by Technology (PCR, NGS), by Application (Non-Healthcare, Healthcare), by End Use, and Segment Forecasts, 2021-2027\" report has been added to ResearchAndMarkets.com's offering. The global synthetic biology market size is estimated to reach USD 31.97 billion by 2027, registering a CAGR of 20.8% Extensive applications of synthetic biology in multiple fields is a major impact rendering driver of the market. For instance, the technique is used for the development of biofuel from microorganisms in the bioenergy field Continue reading